Credit Suisse’s Neos Therapeutics, Inc NEOS Stock Holding History

Credit Suisse’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10,342	Closed	-$26K	–	4293
2019 Q1	$26K	Buy	+10,342	New	+$24.3K	﹤0.01%	3934
2018 Q2	–	Sell	-10,613	Closed	-$88K	–	4219
2018 Q1	$88K	Buy	+10,613	New	+$101K	﹤0.01%	3819
2017 Q4	–	Sell	-17,643	Closed	-$162K	–	4292
2017 Q3	$162K	Buy	+17,643	New	+$134K	﹤0.01%	3990
2017 Q1	–	Sell	-15,544	Closed	-$91K	–	4173
2016 Q4	$91K	Buy	15,544 +5,237	+51%	+$35.4K	﹤0.01%	3962
2016 Q3	$67K	Buy	10,307 +36	+0.4%	+$285	﹤0.01%	3984
2016 Q2	$95K	Buy	+10,271	New	+$98K	﹤0.01%	4069
2015 Q4	–	Sell	-123,305	Closed	-$2.59M	–	4418
2015 Q3	$2.59M	Buy	+123,305	New	+$2.72M	﹤0.01%	2066

Other funds holding NEOS

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Suisse's NEOS Position: Q2 2019 in Review

Credit Suisse sold out of Neos Therapeutics, Inc (NEOS) in Q2 2019, closing a stake of 10,342 shares — an estimated $26K sold.

Credit Suisse first reported a position in NEOS in Q3 2015 and held it in 7 quarters. The position peaked at $2.59M in Q3 2015. 58 funds tracked by Wall St. Rank hold NEOS as of Q2 2019.

Credit Suisse reported no remaining Neos Therapeutics, Inc position as of Q2 2019 after selling out during the quarter.
Credit Suisse sold 10,342 Neos Therapeutics, Inc shares in Q2 2019, an estimated $26K.
Credit Suisse first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 7 quarters.
Credit Suisse's Neos Therapeutics, Inc position peaked at $2.59M in Q3 2015.
58 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2019.

Based on Credit Suisse's 13F filing for Q2 2019, filed 14 Aug 2019.